We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Diligent Pharma Stock

Invest in or calculate the value of your shares in Diligent Pharma or other pre-IPO companies through EquityZen's platform.

Get Started

Diligent Pharma Stock (DIPH)

Diligent Pharma is a platform that streamlines the selection and qualification of clinical trial service providers.

About Diligent Pharma Stock

Founded

2018

Headquarters

Philadelphia, PA, US

Industries

Software, Artificial Intelligence, Data and Analytics

Diligent Pharma is a platform that streamlines the selection and qualification of clinical trial service providers. It simplifies and accelerates the process for identification, selection, and qualification of clinical trial service providers. Trial sponsors can access standardized Vendor Qualification Assessment (VQA) reports and Request for Information (RFI) information from Diligent. As a result, they will require significantly less time and money to qualify a GCP vendor before beginning a clinical investigation.

Diligent Pharma Management

Leadership team at Diligent Pharma

Board Member

Todd Johnson

Founder and Owner

Patricia Leuchten

Locked Features

Join now and verify your accreditation status to gain access to:

  • Diligent Pharma current valuation
  • Diligent Pharma stock price
  • Available deals in Diligent Pharma and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Diligent Pharma stock?

Accredited investors can buy pre-IPO stock in companies like Diligent Pharma through EquityZen funds. These investments are made available by existing Diligent Pharma shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Diligent Pharma stock?

Shareholders can sell their Diligent Pharma stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."